Charles River Laboratories reported quarterly EPS of $2.06, topping the $1.96 Zacks consensus by $0.10, or about 5.1%. Earnings were down from $2.34 per share a year ago, indicating softer year-over-year profitability despite the modest beat. The release is modestly positive for the stock and mainly relevant as an earnings update.
Charles River Laboratories reported quarterly EPS of $2.06, topping the $1.96 Zacks consensus by $0.10, or about 5.1%. Earnings were down from $2.34 per share a year ago, indicating softer year-over-year profitability despite the modest beat. The release is modestly positive for the stock and mainly relevant as an earnings update.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.22
Ticker Sentiment
